Summary
Karim Ghoufiri
Business developper
Technology
- Implantable and resorbable medical device for electric field-directed AXONAL REGROWTH and guidance in treatments of traumatic peripheral, nerve sections.
- This technology is complementary to nerve conduits that work only on small nerve sections at the moment (under 2 – 3 cm)
- The electrodes on the device enhance the axonal regeneration and could promote nerve repair on long gap sections (over 2 – 3 cm)
Results are visible only two weeks after the section.
Market
- ALEF technology enhances existing nerve conduits with active electrical stimulation to guide axonal regeneration. It enables long-gap nerve repair as an alternative to autografts while also improving outcomes in short-gap injuries. With 1.08 million peripheral nerve surgeries annually, the market potential is significant.
Development status
- TRL 3 (In-vivo results)
IP
- PCT Patent application filed 2023/05/24 under n°PCT/IB2023/000262
Valorisation strategy
- Research of industrial partner
- Possible new developments based on industrial specifications